Versant Venture Management as of March 31, 2026
Portfolio Holdings for Versant Venture Management
Versant Venture Management holds 8 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Monte Rosa Therapeutics Common Stock (GLUE) | 37.0 | $52M | 3.2M | 16.45 | |
| Century Therapeutics Common Stock (IPSC) | 19.4 | $28M | 12M | 2.26 | |
| Lenz Therapeutics Common Stock (LENZ) | 17.2 | $24M | 2.7M | 9.15 | |
| Jade Biosciences Common Stock (JBIO) | 15.2 | $21M | 1.5M | 14.05 | |
| Contineum Therapeutics Common Stock (CTNM) | 5.0 | $7.1M | 543k | 13.06 | |
| CRISPR Therapeutics Common Shares (CRSP) | 5.0 | $7.1M | 149k | 47.57 | |
| Skye Bioscience Common Stock (SKYE) | 0.9 | $1.2M | 2.0M | 0.61 | |
| Tempest Therapeutics Common Stock | 0.3 | $442k | 270k | 1.64 |
